Deliver enduring behavioral change with agile, personalized engagement  Precise, Personalized and Proactive- the future of customer engagement is a digitally enabled, hybrid omnichannel strategy.   Heard that all before?     From measuring clicks to measuring behaviour change, the way we think about customer preference has forever been changed. Across marketing, commercial, and medical, the skills we need to deliver on changing […]

Precise, Personalized and Proactive- the future of customer engagement is a digitally enabled, hybrid omnichannel strategy. Heard that all before? From measuring clicks to measuring behaviour change, the way we think about customer preference has forever been changed. Across marketing, commercial, and medical, the skills we need to deliver on changing HCP expectations are aligning. Now […]

With novel RNA-based modalities having seen extraordinary development in the last 18 months, there has never been a more important time for the RNA community to unite, share learnings and accelerate the field towards successful proof of concept and effective therapeutic development. Stay ahead of the curve with novel RNA therapeutics and vaccines that offer […]

4th Annual Cell Engager Summit  May 24-26, 2022 | Boston, MA The 4th Annual Cell Engager Summit returns to bring you the latest on effectively targeting lymphocyte-restricted tumor-associated antigens to treat hematological malignancies, including CD19, CD20, BCMA, CD33, and CD123. This must-attend meeting will provide a comprehensive understanding of the development of multi-specific cell engaging therapeutics in liquid and […]

It has long been understood that the Hippo pathway plays a critical role in the development of a wide range of diseases. Although once seen as an elusive pathway, emerging novel data and research is forging a wider and more developed mechanistic understanding of it. New avenues have been opened to evolve the landscape of […]

As ADCs continue to see clinical success, and as drug design becomes more complex, regulatory scrutiny to ensure product quality is increasing. The trailblazing ADC Analytical Development Summit is the first and only industry focused meeting dedicated to addressing the unique challenges faced by analytical, CMC, QC, process development and protein characterization experts working on ADCs. Covering […]

Uncover the Robust Analytical Methods to Guarantee Safe, High Quality, Consistent & Efficacious Gene Therapy Products In the context of unprecedented gene therapy investment and clinical progress, with mounting regulatory scrutiny, Gene Therapy Analytical Development Europe will unite innovative biotech and pharma organisations to develop robust analytical tools to guarantee the consistency, quality, and safety […]

Integrate the Patient Voice to Develop Safer & More Effective Gene Therapies That Are Meaningful to Patients As investment in gene therapies continues to grow rapidly, more effectively engaging patients throughout development has become a priority for any company serious about building safer and more meaningful gene therapy programs. In this context, the 2nd Annual […]

SMi’s 6th Annual Conference Pre-Filled Syringes West Coast June 13 - 14, 2022 | San Diego, CA, USA SESSING DEVICE DEVELOPMENT AND REGULATION FOR ADVANCED INNOVATION SMi is delighted to announce the 6th annual Pre-Filled Syringes West Coast conference, to be held in San Diego. As part of SMi’s leading series of drug delivery device […]

Outcomes for HER2-expressing breast cancer are patients constantly improving; advancements in diagnostics, trial design and innovative drug design are at an all-time high; complementing the newly accessible HER2 ‘low' space and wider range of tumor indications; the last year has given us more progress in HER2-targeted therapies than ever before. As such, the HER2-Targeted Therapies Summit returns […]

Returning in 2022, the 2nd Tumor Myeloid-Directed Therapeutics Summit is the only industry-focused meeting dedicated to unlocking novel therapeutic potential through the myeloid compartment. This is your ultimate forum to identify, validate, and clinically progress myeloid targets to expand the oncologists toolkit and realize better responses by engaging myeloid anti-tumor function. Designed for experts working directly on myeloid-directed […]

Biotech companies are paving the way to displace the cochlear implant and cater for the huge unmet need in hearing and balance disorders. The field is booming with excitement, with pharma companies increasing investment into these pipelines in the race to successfully reverse hearing damage. Returning as an in-person event to Boston, the 2nd Inner Ear […]

CPhI & P-MEC China is Asia's leading pharmaceutical show for trading, knowledge sharing and networking. It spans all industry sectors along the pharmaceutical supply chain and is your one-stop platform to grow business in the 2nd largest pharma market in the world. CPhI & P-MEC China 2022, with the co-located shows FDF, bioLIVE, Pharma Excipients, […]

The 7th Microbiome Movement - Drug Development Summit returns to Boston at a pivotal time. As the microbiome therapeutic space matures, with more indications being pursued and more companies conducting trials, the focus of this event - now in its 7th year - is evolving to showcase these new studies. With this progress however comes new challenges, and we’re excited […]

Built with biopharmaceutical industry insights, this in-person conference will delve into the latest advancements of non-viral RNA delivery systems such as LNPs, exosomes and polymers to set the scene for the translation of targeted, safe and durable delivery systems for RNA therapeutics and vaccines with improved formulation, distribution and tissue-specificity. Don't miss 20+ pioneering speakers from large […]

Are you using TCRs to target solid tumors yet? With Immunocore having achieved commercialization for the first TCR therapy and Adaptimmune hot on their tail, 2022 is fast becoming the year for TCRs. Join the TCR-based Therapies for Solid Tumors Summit (June 27-29) to gain knowledge to accelerate the clinical development and improve the safety […]

Undoubtedly, the past two years have changed the pharma industry forever; new modalities are dominating pharma pipelines, drugs are increasing in potency, and the restrictions around product quality are tighter than ever before. It is integral that the HPAPI community comes together to apply expertise in ensuring operator safety, alongside product quality, to the future […]

The 8th Annual Microbiome Connect: Europe 2022 dedicated to showcasing the leading drug development and consumer product platforms applying live microbial consortia, engineered microbes, and microbial-derived metabolites for therapeutic and health applications in patients and consumers. As the first EMA approved microbiome-targeted therapeutics emerge on the horizon, drug developers will have to opportunity to benchmark […]

Accelerating Europe's Progress in CNS Gene Therapy Navigating Europe-Specific Challenges & European Regulators Requirements; Optimizing Preclinical Research in Neurological Models & Revolutionizing Gene Therapy Delivery to CNS Targets in the Clinic As programs advance globally, the 3rd Annual Gene Therapy for Neurological Disorders Europe meeting is the industry’s definitive forum dedicated to showcasing the European […]

The Digital Biomarkers & Clinical Measures in Neurology Summit is the definitive industry forum sharing cross-industry insight to transform clinical development with digital data. From integrating wearable technologies, smartphone apps, and speech-based digital biomarkers into remote clinical research to elucidating pathways to clinical validation to establish therapeutic efficacy, join industry experts from Merck, Janssen, GSK, Sanofi, Novartis, Takeda, […]

Migrate Your GxP Regulated Applications to the Cloud with Compliance, Security, & Quality Assurance  With hot anticipation for the FDA’s new CSA guidance, life science companies have the opportunity to take a proactive stance in their approach to the new methodologies. In the climate of this exciting new era of computer systems validation, join over […]

With the undeniable excitement in the BCMA field over the past few months, the BCMA-Targeted Therapies Summit returns to the space to equip you with the knowledge and connections to revolutionize your BCMA-centered pipeline. Pick the brains of 90+ academic and industry pioneers at the first physical edition of the only meeting dedicated to supercharging […]

The Advanced Wound Care Innovation Summit is the first industry-led forum focused on delivering innovative wound care treatments to patients. Expect to hear from, and discuss with, world leaders of wound care research who are driving the development of novel biomaterials, remote-monitoring devices, and digital health management solutions. Find out how C-level Executives, VPs and Directors of R&D are […]

The RNA Therapeutic Modalities Summit is North America’s only industry led conference covering clinical progress and commercial scale development for the full spectrum of RNA therapeutic approaches. Our agenda will featuring the pioneering biotechs translating current vaccine success into further clinically validated treatments in broader indications using RNA technologies such as antisense oligonucleotides, aptamers, small […]

Overcome First Generation Gene Therapy Vector Challenges To Guarantee Targeted, Specific, Efficient & Safe Gene Delivery The 2nd Next Generation Gene Therapy Vectors Summit is dedicated to overcoming the current immunogenicity, toxicity and manufacturability challenges facing the field by pioneering the next generation of superior delivery vectors to deliver safe and efficacious gene therapy products. […]

LEAP HR: Life Sciences East 2022 Conference will be taking place as an in-person event in Boston, July 18-20. Returning as a physical event for its seventh year, this event will showcase 35+ case studies of how life sciences organizations of all stages and sizes are redefining post-pandemic best practices and turbocharging the employee experience […]

Cell Therapy Potency Assay Summit, taking place from 25-27 of July in Boston, will bring together professionals working in analytical development, quality, regulatory and process development functions. Join your peers to: Brainstorm best-in-class approaches to overcome variability in QC Compare next gen approaches from cytotoxicity to omics Develop reference standards to benchmark across the industry […]

The data has dropped and 2022 has been touted as a monumental year for γδT Therapies With Adicet Bio, In8Bio, Gamma Delta Therapeutics, Lava Therapeutics, and ImCheck Therapeutics releasing clinical data from engineered and antibody-based γδT Therapy in patients; the race to market for the first allogeneic and solid tumor-targeting γδT Therapy is truly on. […]

The 3rd Annual B & T Cell-Mediated Autoimmune Disease Drug Development Summit is the only industry-led forum focused on the therapeutic opportunity of drugs directed against B-cell, plasma cell, and T-cell targets in autoimmunity. Several drug approvals for B-cell directed therapies have made waves in autoimmune drug development. As investment and industry momentum increases, this […]

The 3rd Cytokine-Based Drug Development Summit has been developed following extensive research to address YOUR biggest challenges in the cytokine field. With 30+ expert speakers, including the hottest academic researchers and leading figures from the industry, this 4-day program is your opportunity to gain insight into the latest clinical advancement and have thought provoking discussions around how to overcome the […]